Tag: FDA Purple Book
FDA Listing for Biosimilars: How They Are Evaluated and Approved
The FDA doesn't rate biosimilars like generics - it rigorously evaluates them for high similarity and no clinically meaningful differences. Learn how the approval process works, what 'interchangeable' means, and why biosimilars are safe and cost-effective.
DetailRelated Posts
